The clinical hold on NUZ-001 is expected to be lifted in Q1 FY2026, allowing the necessary approvals to commence for the HEALEY ALS Platform Trial.
1.5 Q of operating Capital ,,, so under the 2 Quarter Reg but confident in continuing business.. so must have some Non Dilutive Funding in the wings.. NZT
That bloody money clock never stops ...
Looking forward to the Investor Update Webinar... and on how the other Healey Participants are progressing , any fallen by the way?
- Forums
- ASX - By Stock
- NUZ
- Ann: Appendix 4C & Quarterly Update
NUZ
neurizon therapeutics limited
Add to My Watchlist
5.88%
!
16.0¢

Ann: Appendix 4C & Quarterly Update, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
-0.010(5.88%) |
Mkt cap ! $81.23M |
Open | High | Low | Value | Volume |
16.5¢ | 16.5¢ | 16.0¢ | $7.441K | 45.12K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 223092 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 170799 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 223092 | 0.160 |
5 | 45203 | 0.155 |
3 | 221384 | 0.150 |
4 | 865247 | 0.145 |
3 | 78490 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 170799 | 5 |
0.175 | 177429 | 4 |
0.180 | 94474 | 1 |
0.185 | 125000 | 3 |
0.190 | 24925 | 2 |
Last trade - 11.06am 18/06/2025 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online